Related Experiment Videos
beta-Sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids
1Nutrition Program, State University of New York at Buffalo 14214, USA.
Abstract:
The purpose of the present study was to examine the effect of beta-sitosterol, the main dietary phytosterol on the growth of HT-29 cells, a human colon cancer cell line. In addition, the incorporation of this phytosterol into cellular membranes and how this might influence the lipid composition of the membranes were investigated. Tumor cells were grown in DMEM containing 10% FBS and supplemented with sterols (cholesterol or beta-sitosterol) at final concentrations up to 16 microM. The sterols were supplied to the media in the form of sterol cyclodextrin complexes. The cyclodextrin used was 2-hydroxypropyl-beta-cyclodextrin. The sterol to cyclodextrin molar ratio was maintained at 1:300. The study indicated that 8 and 16 microM beta-sitosterol were effective at cel growth inhibition as compared to cholesterol or to the control (no sterol supplementation). After supplementation with 16 microM beta-sitosterol for 9 days, cell growth was only one-third that of cells supplemented with equimolar concentration of cholesterol. No effect was observed on total membrane phospholipid concentration. At 16 microM beta-sitosterol supplementation, membrane cholesterol was reduced by 26%. Cholesterol supplementation resulted in a significant increase in the cholesterol/phospholipid ratio compared to either beta-sitosterol supplemented cells or controls. There was a 50% reduction in membrane sphingomyelin (SM) of cells grown in 16 microM beta-sitosterol. Additional changes were observed in the fatty acid composition of minor phospholipids of beta-sitosterol supplemented cells, such as SM, phosphatidylserine (PS), and phosphatidylinositol (PI). Only in the case of PI, was there an effect of these fatty acid changes on the unsaturation index, beta-sitosterol incorporation resulted in an increase in the U.I. It is possible that the observed growth inhibition by beta-sitosterol may be mediated through the influence of signal transduction pathways that involve membrane phospholipids.
Insights
Beta-sitosterol, a dietary phytosterol, inhibits human colon cancer cell growth by altering membrane lipid composition. This phytosterol impacts cholesterol and sphingomyelin levels, potentially affecting cell signaling pathways.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Dietary phytosterols, such as beta-sitosterol, are plant-derived compounds with potential health benefits.
- Understanding the cellular mechanisms of phytosterols is crucial for their therapeutic application, particularly in cancer.
- Colon cancer cell lines provide a model for investigating the effects of dietary compounds on cancer progression.
Purpose of the Study:
- To investigate the impact of beta-sitosterol on the proliferation of HT-29 human colon cancer cells.
- To analyze the incorporation of beta-sitosterol into cellular membranes and its effect on membrane lipid composition.
- To explore the relationship between beta-sitosterol-induced membrane changes and cancer cell growth inhibition.
Main Methods:
- HT-29 cells were cultured in DMEM with 10% FBS.
- Cells were supplemented with cholesterol or beta-sitosterol (up to 16 microM) using 2-hydroxypropyl-beta-cyclodextrin complexes.
- Cell growth, membrane lipid composition (cholesterol, phospholipids, sphingomyelin), and fatty acid profiles were analyzed.
Main Results:
- Beta-sitosterol significantly inhibited HT-29 cell growth at concentrations of 8 and 16 microM compared to cholesterol or control.
- Supplementation with 16 microM beta-sitosterol reduced cell growth by two-thirds compared to cholesterol.
- Beta-sitosterol decreased membrane cholesterol by 26% and sphingomyelin by 50%, altering the cholesterol/phospholipid ratio and fatty acid unsaturation index in specific phospholipids.
Conclusions:
- Beta-sitosterol effectively inhibits colon cancer cell growth, likely through modulation of membrane lipid composition.
- Alterations in membrane cholesterol, sphingomyelin, and phospholipid fatty acids by beta-sitosterol may play a role in growth inhibition.
- The findings suggest that beta-sitosterol's anti-cancer effects may involve the regulation of signal transduction pathways influenced by membrane phospholipids.